DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Cell proliferation assay are 8




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_3361Cyclosporine
Antineoplastic and Immunomodulating Agents; Sensory Organ
Immunosuppressant [treatment of transplant (kidney, liver, and heart) rejection], rheumatoid arthritis, severe psoriasis.
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Cell proliferation assay
Decrease (100 %)
Approved
23620378
DrugRepV_3362Cyclosporine
Antineoplastic and Immunomodulating Agents; Sensory Organ
Immunosuppressant [treatment of transplant (kidney, liver, and heart) rejection], rheumatoid arthritis, severe psoriasis.
Middle East respiratory syndrome coronavirus
EMC/2012
NA
Cell proliferation assay
Decrease (80 %)
Approved
23620378
DrugRepV_3453Zanamivir-Flufenamic Acid
Combinational
NA
Influenza virus
pdm09
Pathway
Cell proliferation assay
Decrease (50 %)
NA
29736671
DrugRepV_3454Zanamivir-Clarithromycin
Combinational
NA
Influenza virus
pdm09
Pathway
Cell proliferation assay
Decrease (50 %)
NA
29736671
DrugRepV_3455Zanamivir-Flufenamic Acid-Clarithromycin
Combinational
NA
Influenza virus
pdm09
Pathway
Cell proliferation assay
Decrease (50 %)
NA
29736671
DrugRepV_61812 -C-methyladenosine
NA
NA
Dengue virus
New Guinea C (NGC)
Pathway
Cell proliferation assay
Decrease (50 %)
NA
17662475
DrugRepV_6182Ribavirin
Antiinfectives For Systemic Use
Hepatitis C virus
Dengue virus
New Guinea C (NGC)
Pathway
Cell proliferation assay
Decrease (50 %)
Approved
17662475
DrugRepV_6183Mycophenolic Acid
Antineoplastic and Immunomodulating Agents
Organ rejection (immunosuppressants)
Dengue virus
New Guinea C (NGC)
Pathway
Cell proliferation assay
Decrease (50 %)
Approved
17662475